Owkin agrees to license AI platform and patient data to Servier, Pulse2.com reports
Pulse2.com says the agreement aims to support Servier's cancer research and accelerate the study of hard-to-treat cancers.
Pulse2.com says the agreement aims to support Servier's cancer research and accelerate the study of hard-to-treat cancers.
Pulse2.com reports that Owkin has entered an agreement to license K Pro, its AI Scientist platform, along with multimodal patient data to Servier. The publisher describes the deal as supporting Servier's oncology research, with the goal of speeding up the study of hard-to-treat cancers.
56
1 post, first seen 11h ago
Pulse2.com says the agreement aims to support Servier's cancer research and accelerate the study of hard-to-treat cancers.
Pulse2.com reports that Owkin has entered an agreement to license K Pro, its AI Scientist platform, along with multimodal patient data to Servier. The publisher describes the deal as supporting Servier's oncology research, with the goal of speeding up the study of hard-to-treat cancers.
Not enough discussion yet.
No sentiment analysis available yet.
Not enough discussion yet.
No sentiment analysis available yet.
—
Not ranked yet
—
Not ranked yet